Abstract:Purpose: To investigate Src-like adaptor 2 gene (SLA2) expression in head and neck squamous cell carcinoma (HNSCC), its potential prognostic value, and its effect on immune cell infiltration. Methods: Through a variety of bioinformatics analyses, we extracted and analyzed data sets from the Cancer Genome Atlas (TCGA), Tumor Immune Estimation Resource (TIMER), and Gene Expression Profile Interaction Analysis (GEPIA) to analyze the correlation between SLA2 and the prognosis, immune checkpoint, tumor microenvironment (TME) and immune cell infiltration of HNSCC, and to explore its potential oncogenic mechanism. To further explore the potential role of SLA2 in HNSCC by Gene ontology (GO) functional annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Results: SLA2 messenger ribonucleic acid (mRNA) levels were increased in HNSCC tumor tissues compared with normal tissues. In addition, we found that SLA2 may be an independent prognostic factor for HNSCC, and high SLA2 expression is associated with favorable prognosis in HNSCC. SLA2 expression was positively correlated with B cells, cluster of differentiation 8-positive T cells (CD8 + T cells), cluster of differentiation 4-positive T cells (CD4 + T cells), macrophages, neutrophil and dendritic cells infiltration. SLA2 has also been shown to co-express immune-related genes and immune checkpoints. Significant GO term analysis by Gene Set Enrichment Analysis (GSEA) indicated that genes correlated with SLA2 were located mainly in the side of membrane, receptor complex, secretory granule membrane, endocytic vesicle, membrane region, and endosome membrane, where they were involved in leukocyte cell-cell adhesion, response to interferon-gamma, and regulation of immune effector process. These related genes also served as antigen binding, cytokine receptor activity, phosphatidylinositol 3-kinase activity, peptide receptor activity, Src homology domain 3 (SH3) domain binding, and cytokine receptor binding. KEGG pathway analysis demonstrated that these genes related to SLA2 were mainly enriched in signal pathways, such as hematopoietic cell lineage, cell adhesion molecules (CAMs), natural killer cell mediated cytotoxicity, measles, and chemokine signaling pathway. Conclusions: SLA2 is increased in HNSCC, and high SLA2 expression is associated with favorable prognosis. SLA2 may affect tumor development by regulating tumor infiltrating cells in TME. SLA2 may be a potential target for immunotherapy.

FCGR2A Could Function as a Prognostic Marker and Correlate with Immune Infiltration in Head and Neck Squamous Cell Carcinoma

FCGR1A Serves As a Novel Biomarker and Correlates with Immune Infiltration in Four Cancer Types

Multi-Omics Analyses to Identify FCGBP as a Potential Predictor in Head and Neck Squamous Cell Carcinoma

FCGR3A Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lower-Grade Glioma

FCGBP Functions As a Tumor Suppressor Gene in Head and Neck Squamous Cell Carcinoma

Integrated single-cell and bulk RNA sequencing analysis revealing the role of FCGR2A on prognosis and immune infiltration of hepatocellular carcinoma

Anterior Gradient Protein 2 Expression in High Grade Head and Neck Squamous Cell Carcinoma Correlated with Cancer Stem Cell and Epithelial Mesenchymal Transition

Prognostic significance and gene co-expression network of CD16A and FGL2 in gliomas

Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma

SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment

Identification of SLC2A3 as a prognostic indicator correlated with the NF-kappa B/EMT axis and immune response in head and neck squamous cell carcinoma

Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity

PLAU and LAMC2 can predict a poor prognosis in patients with HNSCC

The Expression and Prognosis Prediction of CFL-1 in Head and Neck Squamous Cell Carcinoma

High Eukaryotic Initiation Factor 5A2 Expression Predicts Poor Prognosis and May Participate in the SNHG16/miR-10b-5p/EIF5A2 Regulatory Axis in Head and Neck Squamous Cell Carcinoma

Prognostic Value of CAV1 and CAV2 in Head and Neck Squamous Cell Carcinoma.

NTF2 Upregulation in HNSCC: a Predictive Marker and Potential Therapeutic Target Associated With Immune Infiltration

RFC2: a Prognosis Biomarker Correlated with the Immune Signature in Diffuse Lower-Grade Gliomas

Integrated analysis of single‐cell RNA‐seq and bulk RNA‐seq unravels the molecular feature of M2 macrophages of head and neck squamous cell carcinoma

A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma

High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma.